Search results for: Alzheimer’s
The Future of Amyloid-fighting Drugs Alzheimer’s Disease and Radiology
In the next few years, expect amyloid-fighting drugs to treat Alzheimer’s disease to be an emerging category of more commonly-used monoclonal antibodies. Researchers, led by Petrice Cogswell, MD, PhD, of the Mayo Clinic, recommend that both neuroradiologists and general radiologists become familiar with the treatment-related side effects caused by amyloid-related imaging abnormalities (ARIAs). The researchers’…
Read MoreStudy finds Amyloid Blood Tests for May Cut Need for PET in Half
Study authors suggest that the positive result of using the blood test methods may lead to faster clinical trial recruitment. A recent study by authors Ashvini Keshavan, Josef Pannee, et al. aimed to evaluate population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70. Alzheimer’s disease affects more than 5…
Read MoreNew PET tracer and Parkinson’s disease
Parkinson’s disease (PD) affects about 1.2 percent of the elderly population, who are 71 years of age or older, worldwide. In the U.S., it is estimated that 60,000 Americans receive a PD diagnosis each year. Males are one and a half times more likely to develop Parkinson’s disease than females are. With the anticipated changes…
Read More